Cargando…
Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176025/ https://www.ncbi.nlm.nih.gov/pubmed/35844696 http://dx.doi.org/10.1002/jha2.205 |
_version_ | 1784722573564575744 |
---|---|
author | Garrido Paniagua, Sara Prieto Martínez, Pablo Cachón, Rafael Forés Bautista Carrascosa, Guiomar Duarte, Rafael F. Krsnik, Isabel |
author_facet | Garrido Paniagua, Sara Prieto Martínez, Pablo Cachón, Rafael Forés Bautista Carrascosa, Guiomar Duarte, Rafael F. Krsnik, Isabel |
author_sort | Garrido Paniagua, Sara |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9176025 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91760252022-07-14 Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma Garrido Paniagua, Sara Prieto Martínez, Pablo Cachón, Rafael Forés Bautista Carrascosa, Guiomar Duarte, Rafael F. Krsnik, Isabel EJHaem Haematology Images John Wiley and Sons Inc. 2021-05-07 /pmc/articles/PMC9176025/ /pubmed/35844696 http://dx.doi.org/10.1002/jha2.205 Text en © 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Haematology Images Garrido Paniagua, Sara Prieto Martínez, Pablo Cachón, Rafael Forés Bautista Carrascosa, Guiomar Duarte, Rafael F. Krsnik, Isabel Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma |
title | Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma |
title_full | Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma |
title_fullStr | Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma |
title_full_unstemmed | Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma |
title_short | Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma |
title_sort | secondary effects after belantamab treatment: a new anti‐b‐cell maturation antigen monoclonal antibody for multiple myeloma |
topic | Haematology Images |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176025/ https://www.ncbi.nlm.nih.gov/pubmed/35844696 http://dx.doi.org/10.1002/jha2.205 |
work_keys_str_mv | AT garridopaniaguasara secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma AT prietomartinezpablo secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma AT cachonrafaelfores secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma AT bautistacarrascosaguiomar secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma AT duarterafaelf secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma AT krsnikisabel secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma |